JP2016512513A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016512513A5 JP2016512513A5 JP2016500995A JP2016500995A JP2016512513A5 JP 2016512513 A5 JP2016512513 A5 JP 2016512513A5 JP 2016500995 A JP2016500995 A JP 2016500995A JP 2016500995 A JP2016500995 A JP 2016500995A JP 2016512513 A5 JP2016512513 A5 JP 2016512513A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- individual
- item
- tumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010028980 Neoplasm Diseases 0.000 claims description 12
- 229940123237 Taxane Drugs 0.000 claims description 12
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 9
- 239000002105 nanoparticle Substances 0.000 claims description 9
- 102000009027 Albumins Human genes 0.000 claims description 8
- 108010088751 Albumins Proteins 0.000 claims description 8
- 208000006678 Abdominal Neoplasms Diseases 0.000 claims description 2
- 208000018084 Bone neoplasm Diseases 0.000 claims description 2
- 206010029260 Neuroblastoma Diseases 0.000 claims description 2
- 229930012538 Paclitaxel Natural products 0.000 claims description 2
- 206010039491 Sarcoma Diseases 0.000 claims description 2
- 206010068771 Soft tissue neoplasm Diseases 0.000 claims description 2
- 208000021712 Soft tissue sarcoma Diseases 0.000 claims description 2
- 208000024519 eye neoplasm Diseases 0.000 claims description 2
- 229960001592 paclitaxel Drugs 0.000 claims description 2
- 230000000306 recurrent effect Effects 0.000 claims description 2
- 201000009410 rhabdomyosarcoma Diseases 0.000 claims description 2
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims description 2
- 238000002560 therapeutic procedure Methods 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 25
- 238000000034 method Methods 0.000 description 21
- 230000002250 progressing effect Effects 0.000 description 1
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361780658P | 2013-03-13 | 2013-03-13 | |
| US61/780,658 | 2013-03-13 | ||
| US201361805817P | 2013-03-27 | 2013-03-27 | |
| US61/805,817 | 2013-03-27 | ||
| US201361829940P | 2013-05-31 | 2013-05-31 | |
| US61/829,940 | 2013-05-31 | ||
| US201361909868P | 2013-11-27 | 2013-11-27 | |
| US61/909,868 | 2013-11-27 | ||
| PCT/US2014/022541 WO2014143613A1 (en) | 2013-03-13 | 2014-03-10 | Methods of treatment of pediatric solid tumor |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018009402A Division JP2018062528A (ja) | 2013-03-13 | 2018-01-24 | 小児充実性腫瘍の処置の方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016512513A JP2016512513A (ja) | 2016-04-28 |
| JP2016512513A5 true JP2016512513A5 (enExample) | 2017-04-06 |
| JP6387389B2 JP6387389B2 (ja) | 2018-09-05 |
Family
ID=51537501
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016500995A Active JP6387389B2 (ja) | 2013-03-13 | 2014-03-10 | 小児充実性腫瘍の処置の方法 |
| JP2018009402A Withdrawn JP2018062528A (ja) | 2013-03-13 | 2018-01-24 | 小児充実性腫瘍の処置の方法 |
| JP2019124315A Pending JP2019163334A (ja) | 2013-03-13 | 2019-07-03 | 小児充実性腫瘍の処置の方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018009402A Withdrawn JP2018062528A (ja) | 2013-03-13 | 2018-01-24 | 小児充実性腫瘍の処置の方法 |
| JP2019124315A Pending JP2019163334A (ja) | 2013-03-13 | 2019-07-03 | 小児充実性腫瘍の処置の方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20160015817A1 (enExample) |
| EP (1) | EP2968253A4 (enExample) |
| JP (3) | JP6387389B2 (enExample) |
| KR (1) | KR20150126671A (enExample) |
| CN (1) | CN105209035A (enExample) |
| AU (2) | AU2014228386B2 (enExample) |
| CA (1) | CA2903470A1 (enExample) |
| HK (1) | HK1219231A1 (enExample) |
| IL (1) | IL240987A0 (enExample) |
| MX (1) | MX2015011783A (enExample) |
| NZ (1) | NZ630367A (enExample) |
| WO (1) | WO2014143613A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8735394B2 (en) | 2005-02-18 | 2014-05-27 | Abraxis Bioscience, Llc | Combinations and modes of administration of therapeutic agents and combination therapy |
| JP5933893B2 (ja) | 2006-12-14 | 2016-06-15 | アブラクシス バイオサイエンス， エルエルシー | ホルモン受容体状態に基づいてタキサンを含むナノ粒子用いる乳癌治療法 |
| ME03596B (me) | 2009-04-15 | 2020-07-20 | Abraxis Bioscience Llc | Kompozicije nanočesтica bez priona i postupci povezani sa njima |
| CA2794147A1 (en) | 2010-03-29 | 2011-10-06 | Abraxis Bioscience, Llc | Use of a composition comprising nanoparticles comprising a taxane and an albumin to improve uptake of chemotherapeutics by tumors and for treating a cancer that is highly fibrotic and/or has a dense stroma |
| KR101894689B1 (ko) | 2010-03-29 | 2018-09-04 | 아브락시스 바이오사이언스, 엘엘씨 | 암의 치료 방법 |
| EP2575804A4 (en) | 2010-06-04 | 2013-10-23 | Abraxis Bioscience Llc | METHOD FOR THE TREATMENT OF PANCREASCRE |
| KR101970342B1 (ko) | 2011-04-28 | 2019-04-18 | 아브락시스 바이오사이언스, 엘엘씨 | 나노입자 조성물의 혈관내 전달 및 그의 용도 |
| EP3560486A1 (en) | 2011-12-14 | 2019-10-30 | Abraxis BioScience, LLC | Use of polymeric excipients for lyophilization or freezing of particles |
| US9149455B2 (en) | 2012-11-09 | 2015-10-06 | Abraxis Bioscience, Llc | Methods of treating melanoma |
| US9511046B2 (en) | 2013-01-11 | 2016-12-06 | Abraxis Bioscience, Llc | Methods of treating pancreatic cancer |
| CA2903454A1 (en) | 2013-03-12 | 2014-10-02 | Abraxis Bioscience, Llc | Methods of treating lung cancer |
| EP2968191B1 (en) | 2013-03-14 | 2021-06-16 | Abraxis BioScience, LLC | Methods of treating bladder cancer |
| US10705070B1 (en) | 2015-03-05 | 2020-07-07 | Abraxis Bioscience, Llc | Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug |
| US10527604B1 (en) | 2015-03-05 | 2020-01-07 | Abraxis Bioscience, Llc | Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel |
| EA036790B1 (ru) | 2015-06-29 | 2020-12-22 | АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи | Способ лечения злокачественной пекомы |
| EP3768268A4 (en) | 2018-03-20 | 2022-02-23 | Abraxis BioScience, LLC | METHOD OF TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS BY ADMINISTRATION OF NANOPARTICLES OF AN MTOR INHIBITOR AND AN ALBUMINE |
| EP4051241A4 (en) | 2019-10-28 | 2023-12-06 | Abraxis BioScience, LLC | PHARMACEUTICAL COMPOSITIONS OF ALBUMIN AND RAPAMYCIN |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6749868B1 (en) | 1993-02-22 | 2004-06-15 | American Bioscience, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| US6096331A (en) | 1993-02-22 | 2000-08-01 | Vivorx Pharmaceuticals, Inc. | Methods and compositions useful for administration of chemotherapeutic agents |
| US5916596A (en) | 1993-02-22 | 1999-06-29 | Vivorx Pharmaceuticals, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| US6537579B1 (en) | 1993-02-22 | 2003-03-25 | American Bioscience, Inc. | Compositions and methods for administration of pharmacologically active compounds |
| CN1101700C (zh) * | 1997-12-05 | 2003-02-19 | 上海众联生化技术开发有限公司 | 多肽口服液 |
| ITMI20001107A1 (it) * | 2000-05-18 | 2001-11-18 | Acs Dobfar Spa | Metodo per il trattamento di tumori solici mediante microparticelle di albumina incorporanti paclitaxel |
| DK1585548T3 (en) | 2002-12-09 | 2018-09-03 | Abraxis Bioscience Llc | COMPOSITIONS AND PROCEDURES FOR THE DELIVERY OF PHARMACOLOGICAL AGENTS |
| CN1261161C (zh) * | 2003-11-10 | 2006-06-28 | 钱汶光 | 复方干扰素诱生剂口含片 |
| SG166775A1 (en) | 2005-02-18 | 2010-12-29 | Abraxis Bioscience Llc | Combinations and modes of administration of therapeutic agents and combination therapy |
| US8034765B2 (en) | 2005-08-31 | 2011-10-11 | Abraxis Bioscience, Llc | Compositions and methods for preparation of poorly water soluble drugs with increased stability |
| US20100166869A1 (en) | 2007-05-03 | 2010-07-01 | Desai Neil P | Methods and compositions for treating pulmonary hypertension |
| AU2010321773A1 (en) * | 2009-11-20 | 2012-06-14 | Infinity Pharmaceuticals, Inc. | Methods and compositions for treating hedgehog-associated cancers |
| CA2794147A1 (en) * | 2010-03-29 | 2011-10-06 | Abraxis Bioscience, Llc | Use of a composition comprising nanoparticles comprising a taxane and an albumin to improve uptake of chemotherapeutics by tumors and for treating a cancer that is highly fibrotic and/or has a dense stroma |
| WO2011153009A1 (en) * | 2010-06-02 | 2011-12-08 | Abraxis Bioscience, Llc | Methods of treating bladder cancer |
-
2014
- 2014-03-10 KR KR1020157027992A patent/KR20150126671A/ko not_active Ceased
- 2014-03-10 US US14/771,783 patent/US20160015817A1/en not_active Abandoned
- 2014-03-10 HK HK16107309.3A patent/HK1219231A1/zh unknown
- 2014-03-10 NZ NZ630367A patent/NZ630367A/en unknown
- 2014-03-10 EP EP14763546.0A patent/EP2968253A4/en not_active Withdrawn
- 2014-03-10 AU AU2014228386A patent/AU2014228386B2/en not_active Ceased
- 2014-03-10 WO PCT/US2014/022541 patent/WO2014143613A1/en not_active Ceased
- 2014-03-10 MX MX2015011783A patent/MX2015011783A/es unknown
- 2014-03-10 CN CN201480026752.3A patent/CN105209035A/zh active Pending
- 2014-03-10 JP JP2016500995A patent/JP6387389B2/ja active Active
- 2014-03-10 CA CA2903470A patent/CA2903470A1/en not_active Abandoned
-
2015
- 2015-09-01 IL IL240987A patent/IL240987A0/en unknown
-
2018
- 2018-01-24 JP JP2018009402A patent/JP2018062528A/ja not_active Withdrawn
-
2019
- 2019-02-27 AU AU2019201357A patent/AU2019201357A1/en not_active Abandoned
- 2019-07-03 JP JP2019124315A patent/JP2019163334A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016512513A5 (enExample) | ||
| MX2019013701A (es) | Metodos para mejorar suministro de farmacos y efectividad de agentes terapeuticos. | |
| Wieszczycka et al. | Lanthanides and tissue engineering strategies for bone regeneration | |
| JP2016513075A5 (enExample) | ||
| JP2016513097A5 (enExample) | ||
| JP2013503174A5 (enExample) | ||
| JP2016513657A5 (enExample) | ||
| JP2010509331A5 (enExample) | ||
| JP2013523656A5 (enExample) | ||
| JP2012520323A5 (enExample) | ||
| NZ708506A (en) | Methods of treating bladder cancer | |
| JP2016512506A5 (enExample) | ||
| JP2017226708A5 (enExample) | ||
| JP2013527233A5 (enExample) | ||
| RU2009121568A (ru) | Комбинации и способы введения терапевтических агентов и комбинированная терапия | |
| JP2014518275A5 (enExample) | ||
| MX2017016492A (es) | Metodos para tratar tumores solidos usando terapia de combinacion de nanoparticula del inhibidor del objetivo mamifero de la rapamicina (mtor). | |
| JP2013533232A5 (enExample) | ||
| CA3024135C (en) | Compositions intended for the administration of RNA in the form of nanoparticles and associated method of use | |
| NZ593343A (en) | Combination cancer treatment conprising Abraxane and an inflamatory inhibitor | |
| JP2013527232A5 (enExample) | ||
| ME02470B (me) | Nanočesтice nabijene sa hemoterapeutskim anтitumorskim lekom | |
| WO2015095834A3 (en) | Cancer treatments using erk1/2 and bcl-2 family inhibitors | |
| JP2021505540A5 (enExample) | ||
| JP2015502926A5 (enExample) |